Coronavirus disease 2019 (Covid‐2019) has been associated with several cutaneous manifestations(1–3). A temporary field hospital was implemented during the pandemic peak in Madrid, Spain, to attend COVID‐19 patients with mild to moderate pneumonia.
Lately we have witnessed sporadic reports of Pityriasis Rosea (PR) and PR‐like eruptions associated with SARS‐CoV‐2. Such relationship has raised debate on the possible etiopathogenic mechanism underlying this exanthematous disease. Our aim is to reinforce the link between PR and coronaviruses based on our finding of two cases following COVID‐19 vaccination – the first to our knowledge – and two cases related to SARS‐Cov‐2 infection.
2 July 2020 in Journal of the European Academy of Dermatology and Venereology
Reports on COVID‐19 in children are limited. Despite new data emerging, and understanding of the disease improves rapidly, there are as yet several features and complications related to the disease that remain unknown. Herein, we report the first case of a child with chilblains and retinal vasculitis related to COVID‐19.